Publication Cover
Nutritional Neuroscience
An International Journal on Nutrition, Diet and Nervous System
Volume 6, 2003 - Issue 2
20
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Sibutramine Decreases Body Weight Gain and Increases Energy Expenditure in Obese Zucker Rats without Changes in NPY and Orexins

, , , , , & show all
Pages 103-111 | Published online: 05 Sep 2013

References

  • Acebes, I., Saracibar, G., Echevarria, E., Casado, A., Valiente, F.J., Pascual, J. and Casis, L. (2002 ) “Selective serotonin reuptake inhibitors alter NPY immunostaining in the rat hypothalamus”, Neuroscience Research Communications 30, 185–196.
  • AOAC International (1997 ) In: Cunniff, P., ed, Official Methods of Analysis of AOAC International, 16th Ed. (AOAC International, Githersburg).
  • Beck, B., Burlet, A., Nicolas, J.P. and Burlett, C. (1990 ) “Hypothalamic neuropeptide Y (NPY) in obese Zucker rats: implications in feeding and sexual behaviours”, Physiology and Behaviour 47, 449–453.
  • Beck, B., Burlet, A., Bazin, R., Nicolas, J.P. and Burlet, C. (1993 ) “Elevated neuropeptide Y in the arcuate nucleus of young obese Zucker rats may contribute to the development of their overeating”, Journal of Nutrition 123, 1168–1172.
  • Beck, B., Richy, S., Dimitrov, T. and Stricker-Krongrad, A. (2001 ) “Opposite regulation of hypothalamic orexin and neuropeptide Y receptors and peptide expressions in obese Zucker rats”, Biochemical and Biophysical Research Communications 286, 518–523.
  • Bray, G.A. (1977 ) “The Zucker-fatty rat: a review”, Federation Proceedings 36, 148–153.
  • Brown, M., Bing, C., King, P., Pickavance, L., Heal, D. and Wilding, J. (2001 ) “Sibutramine reduces feeding, body fat and improves insulin resistance in dietary-obese male Wistar rats independently of hypothalamic neuropeptide Y”, British Journal of Pharmacology 132, 1898–1904.
  • Buckett, W.R., Thomas, P.C. and Luscombe, G.P. (1988 ) “The pharmacology of sibutramine hydrochloride (BTS 54524), a new antidepressant which induces rapid noradrenergic down-regulation”, Progress on Neuropsychopharmacology and Biological Psychiatry 12, 575–584.
  • Chronwall, B.M., Di Maggio, D.A., Massari, V.J., Pickel, V.M., Ruggiero, D.A. and O’Donohue, T.L. (1985 ) “The anatomy of the neuropeptide Y containing neurons in the rat brain”, Journal of Neuroscience 15, 1159–1181.
  • Connoley, I.P., Yong-Ling, L., Frost, I., Reckless, I.P., Heal, D.J. and Stock, M. (1999 ) “Thermogenic effects of sibutramine and its metabolites”, British Journal of Pharmacology 126, 1487–1495.
  • Cusin, I., Rohner-Jeanrenaud, F., Stricker-Kongrad, A. and Jeanrenaud, B. (1996 ) “The weight-reducing effects of an intracerebroventricular bolus injection of leptin in genetically obese fa/fa rats”, Diabetes 45, 1446–1450.
  • De Fanti, B.A., Hamilton, J.S. and Horwitz, B.A. (2001 ) “Meal- induced changes in extracellular 5-HT in medial hypothalamus of lean (Fa/Fa) and obese (fa/fa) Zucker rats”, Brain Research 902, 164–170.
  • Dryden, S., Pickavance, L., Frankish, H.M. and Williams, G. (1995 ) “Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rat”, Brain Research 690, 185–188.
  • Dryden, S., Frankish, H.M., Wang, Q., Pickavance, L. and Williams, G. (1996 ) “The serotoninergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats”, Neuroscience 72, 557–566.
  • Dube, M.G., Horvath, T.L., Kalra, P.S. and Kalra, S.P. (2000 ) “Evidence of NPY Y5 receptor involvement in food intake elicited by orexin A in satiated rats”, Peptides 21, 1557–1560.
  • Fabris, R., Granzotto-Pagano, C., Lombardi, A.M., Ferretti, E., Marzolo, M., Seagnol, I., Federspil, G. and Vettor, R. (2000 ) “Effect of sibutramine on glucose metabolism in genetically obese ( fa/fa) rats”, International Journal ofObesity 24(Suppl. 2), S124–S126.
  • Grignaschi, G., Fanelli, E., Scagnol, I. and Samanin, R. (1999 ) “Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats”, British Journal of Pharmacology 127, 1190–1194.
  • Gutierrez, A., Saracibar, G., Casis, L., Echevarria, E., Rodriguez, V.M., Macarulla, M.T., Abecia, L.C. and Portillo, M.P. (2002 ) “Effects of fluoxetine administration on NPY and orexins in obese Zucker rat hypothalamus”, Obesity Research 10, 532–540.Guy, J., Pelletier, G. and Bosier, O. (1988) “Serotonin innervation of neuropeptide Y containing neurons in the rat arcuate nucleus”, Neuroscience Letters 85, 9–13.
  • Halford, J.C.G., Heal, D.J. and Blundell, J.E. (1995 ) “Effects in the rat of sibutramine on food intake and the behavioral satiety sequence”, British Journal of Pharmacology 114, 387.
  • Heal, D.J., Cheetham, S.C., Prow, M.R., Martin, K.F. and Buckett, W.R. (1998 ) “A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight- modifying agents”, British Journal of Pharmacology 125, 301–308.
  • Jackson, H.C., Bearham, M.C., Hutchins, L.J., Mazurkiewicz, S.E., Needham, A.M. and Heal, D.J. (1997 ) “Investigation of the mechanism underlying the hypophagic effects of 5-HT and noradrenaline reuptake inhibitor sibutramine, in the rat”, British Journal of Pharmacology 121, 1613–1618.
  • Jhanwar-Uniyal, M., Awad, I.R., Gearhart, G.M., Finkelstein, J.A. and Leibowitz, S.F. (1991), Pharmacology, Biochemistry and Behavior 40, 853–859.
  • Jung, R.T. (1997 ) “Obesity and nutritional factors in the pathogenesis of non-insulin dependent diabetes mellitus ”, In: Pickup, J.C. and Williams, G., eds, Textbook of Diabetes (Blackwell Science, Oxford ), pp. 17–23.
  • Le Feuvre, R.A., Aisenthal, L. and Rothwell, N.J. (1991 ) “Involvement of corticotropin-releasing factor (CRF) in the thermogenic and anorectic actions of serotonine (5-HT) and related compounds”, Brain Research 555, 245–250.
  • Leibowitz, S.F., Weiss, G.F. and Suh, J. (1990 ) “Medium hypothalamic nuclei mediate serotonin’s inhibitory effect on feeding behaviour”, Pharmacology, Biochemistry and Behavior 37, 735–742.
  • Lungdberg, J.M., Terenius, L., Hokfelt, T., Martling, C.R., Tatemoto, K., Mutt, V., Polak, J., Bloom, S. and Goldstein, M. (1982 ) “Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects on NPY on sympathetic function”, Acta Physiologica Scandinavica 116, 479–480.
  • Luscombe, G.P., Hopcroft, R.H., Thomas, P.C. and Burckett, W.R. (1989 ) “The contribution of metabolites to the rapid and potent down-regulation of rat cortical ß-adrenoceptors by the putative antidepressant sibutramine hydrochloride”, Neuropharmacology 28, 129–134.
  • McKibbin, P.E., Cotton, S.J., McMillan, S., Holloway, B., Mayers, R., McCarthy, H.D. and Williams, G. (1991 ) “Altered neuropeptide Y concentrations in specific hypothalamic regions of obese ( fa/fa) Zucker rats. Possible relationship to obesity and neuroendocrine disturbances”, Diabetes 40, 1423–1429.
  • Orosco, M., Rouch, C., Meile, M.J. and Nicolaidis, S. (1995 ) “Spontaneous feeding-related monoamine changes in rostro- medial hypothalamus of the obese Zucker rat: a microdialysis study”, Physiology and Behavior 57, 1103–1106.
  • Phillips, M.S., Liu, Q.Y., Hammond, H.A., Dugan, V., Hey, P.J., Caskey, C.T. and Hess, J.F. (1996 ) “Leptin receptor missense mutation in fatty Zucker rat”, Nature Genetics 13, 18–19.
  • Rogers, P., McKibbin, P.E. and Williams, G. (1991 ) “Acute fenfluramine administration reduces neuropeptide Y concentration in specific hypothalamic regions of the rat. Possible implications for the anorectic effect of fenfluramine”, Peptides 12, 251–255.
  • Rohner-Jenrenaud, F., Cusin, I., Sainsbury, A., Zakrzewska, K.E. and Jeanrenaud, B. (1996 ) “The loop system between neuropeptide Y and leptin in normal and obese rodents”, Hormone and Metabolic Research 28, 642–648.
  • Routh, V.H., Murakami, D.M., Stern, J.S., Fuller, C.A. and Horwitz, B.A. (1990 ) “Neuronal activity in hypothalamic nuclei of obese and lean Zucker rats”, International Journal ofObesity 14, 879–891.
  • Routh, V.H., Stern, J.S. and Horwitz, B.A. (1994) “Serotonergic activity is depressed in the ventromedial hypothalamic nucleus of 12-day-old obese Zucker rats”, American Journal of Physiology 267, R712–R7119.
  • Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R.M., Tanaka, H., Williams, S.C., Richardson, J.A., Kozlowski, G.P., Wilson, S., Arch, J.R.S., Buckingham, R.E., Haynes, A.C., Carr, S.A., Annan, R.S., McNulty, D.E., Liu, W.S., Terrett, J.A., Elshourbagy, N.A., Bergsma, D.J. and Yanagisawa, M. (1998 ) “Orexins and orexin receptors. A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behaviour”, Cell 92, 573–585.
  • Sawchencko, P.E., Swanson, L.W., Steinbush, H.W.M. and Verhofstad, A.J. (1983 ) “The distribution and cells of origin of serotoninergic inputs to the paraventricular and supraoptic nuclei of the rat”, Brain Research 277, 355–360.
  • Schwartz, M.W., Baskin, D.G., Bukowski, T.R., Kuijper, J.L., Foster, D., Lasser, G., Prunkard, E., Porte, D., Woods, S.C., Seeley, R. and Weigle, D.S. (1996 ) “Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice”, Diabetes 45, 531–535.
  • Stricker-Kongrad, A., Souquet, A.M. and Burlet, C. (1995 ) “Effects of sibutramine on feeding behaviour in obese and lean Zucker rats”, International Journal of Obesity 19(Suppl. 2), 398.
  • Svec, F., Thompson, C., Corll, C. and Porter, J. (2002 ) “Levels of hypothalamic neurotransmitters in lean and obese Zucker rats”, Nutritional Neuroscience 5, 321–326.
  • Vasselli, J.R., Fiene, J.A. and Maggio, C.A. (1992) “Relationship of adipocyte size to hyperphagia in developing male obese Zucker rats”, American Journal ofPhysiology 262, R33–R38.
  • Wellman, P.J., Becky, T.D., Morien, A. and McMahon, L. (1993 ) “Modulation of feeding by hypothalamic paraventricular nucleus α1- and α2-adrenergic receptors”, Life Sciences 53, 669–679.
  • Wellman, PJ. (2000 ) “Norepinephrine and the control of food intake”, Nutrition 16, 837–842.
  • White, B.D. and Martin, R.J. (1997) “Evidence for a central mechanism of obesity in the Zucker rat: role of neuropeptide Y and leptin”, Proceedings ofSociety ofExperimental Biology and Medicine 214, 222–232.
  • Widdowson, P.S. (1995 ) “Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 feeding receptor”, Brain Research 758, 17–25.
  • Wilding, J.P., Gilbey, S.G., Jones, S.G., Mannan, M.M., Ghatei, M.A. and Bloom, S.R. (1992 ) “Dexfenfluramine treatment and hypothalamic neuropeptides in diet-induced obesity in rats”, Peptides 13, 557–563.
  • Wolf, G. (1997 ) “Neuropeptides responding to leptin”, Nutrition Reviews 55, 85–88.
  • Yarnell, D.O., Knight, D.S., Hamilton, K., Tulp, O. and Tso, P. (1998 ) “Localization of leptin receptor immunoreactivity in the lean and obese Zucker rat brain”, Brain Research 758, 80–90.
  • Zarjevski, N., Cusin, I., Vettor, R., Rhoner-Jeanrenaud, F. and Jeanrenaud, B. (1993 ) “Chronic intracerebroventricular neuro- peptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity”, Endocrinology 133, 1756–1758.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.